Evopoint Biosciences Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Public

  • Employees
  • 50

Employees

  • Stock Symbol
  • 688837

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $4.71
  • (As of Thursday Closing)

Evopoint Biosciences General Information

Description

Evopoint Biosciences Co Ltd is a biopharmaceutical company engaged in the research, development, and commercialization of drugs.

Contact Information

Formerly Known As
Suzhou Sinov Pharmaceutical Technology
Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Corporate Office
  • Building 22, Phase II, Bio-industry Park
  • Number 218 Sangtian Road
  • Suzhou, Jiangsu 215000
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • Building 22, Phase II, Bio-industry Park
  • Number 218 Sangtian Road
  • Suzhou, Jiangsu 215000
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Evopoint Biosciences Stock Performance

As of 19-Nov-2026, Evopoint Biosciences’s stock price is $4.71. Its current market cap is $2.05B with 435M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.71 $4.94 $4.69 - $11.77 $2.05B 435M 11M -$0.18

Evopoint Biosciences Financials Summary

As of 30-Sep-2026, Evopoint Biosciences has a trailing 12-month revenue of $34.1M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 3,255,514
Revenue 34,057 130,052 0 0
EBITDA (60,421) 49,036 (48,339) (57,105)
Net Income (65,746) 28,167 (53,794) (60,338)
Total Assets 538,413 249,087 149,078 160,336
Total Debt 196,651 128,382 71,434 58,153
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Evopoint Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Evopoint Biosciences‘s full profile, request access.

Request a free trial

Evopoint Biosciences Patents

Evopoint Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026189357-A1 Pharmaceutical composition comprising β-lactamase inhibitor and use thereof Pending 10-Mar-2025
WO-2026171195-A1 Pharmaceutical composition comprising piperidine ring compound, and use thereof Pending 12-Feb-2025
WO-2026153068-A1 Dihydropyrazolopyridinone compound and use thereof Pending 14-Jan-2025
WO-2026145506-A1 Pharmaceutical composition comprising polysubstituted benzene ring compound, and use method therefor Pending 30-Dec-2024
WO-2026086944-A1 Aminopyridone macrolide compound and use thereof Pending 24-Oct-2024 C07H17/00
To view Evopoint Biosciences’s complete patent history, request access »

Evopoint Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Evopoint Biosciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Evopoint Biosciences‘s full profile, request access.

Request a free trial

Evopoint Biosciences Investments (1)

Evopoint Biosciences’s most recent deal was a Early Stage VC with MediLink Therapeutics. The deal was made on 13-Dec-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MediLink Therapeutics 13-Dec-2020 Early Stage VC Drug Discovery
To view Evopoint Biosciences’s complete investments history, request access »

Evopoint Biosciences FAQs

  • When was Evopoint Biosciences founded?

    Evopoint Biosciences was founded in 2017.

  • Where is Evopoint Biosciences headquartered?

    Evopoint Biosciences is headquartered in Suzhou, China.

  • What is the size of Evopoint Biosciences?

    Evopoint Biosciences has 50 total employees.

  • What industry is Evopoint Biosciences in?

    Evopoint Biosciences’s primary industry is Drug Discovery.

  • Is Evopoint Biosciences a private or public company?

    Evopoint Biosciences is a Public company.

  • What is Evopoint Biosciences’s stock symbol?

    The ticker symbol for Evopoint Biosciences is 688837.

  • What is the current stock price of Evopoint Biosciences?

    As of 19-Nov-2026 the stock price of Evopoint Biosciences is $4.71.

  • What is the current market cap of Evopoint Biosciences?

    The current market capitalization of Evopoint Biosciences is $2.05B.

  • What is Evopoint Biosciences’s current revenue?

    The trailing twelve month revenue for Evopoint Biosciences is $34.1M.

  • What is Evopoint Biosciences’s annual earnings per share (EPS)?

    Evopoint Biosciences’s EPS for 12 months was -$0.18.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process